163 related articles for article (PubMed ID: 35732647)
1. HDAC6 is a prognostic biomarker that mediates IL-13 expression to regulate macrophage polarization through AP-1 in oral squamous cell carcinoma.
Tseng CC; Huang SY; Tsai HP; Wu CW; Hsieh TH
Sci Rep; 2022 Jun; 12(1):10513. PubMed ID: 35732647
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological blockade of HDAC6 attenuates cancer progression by inhibiting IL-1β and modulating immunosuppressive response in OSCC.
Mahale A; Routholla G; Lavanya S; Sharma P; Ghosh B; Kulkarni OP
Int Immunopharmacol; 2024 May; 132():111921. PubMed ID: 38547770
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma.
Tavares MO; Milan TM; Bighetti-Trevisan RL; Leopoldino AM; de Almeida LO
J Oral Pathol Med; 2022 Jul; 51(6):529-537. PubMed ID: 35678235
[TBL] [Abstract][Full Text] [Related]
4. [Periodontitis Promotes the Progression of Oral Squamous Cell Carcinoma by Inducing Macrophage M2 Polarization].
Li J; Wei W; Tang BY; Li Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 54(1):83-90. PubMed ID: 36647648
[TBL] [Abstract][Full Text] [Related]
5. OSCC cell-secreted exosomal CMTM6 induced M2-like macrophages polarization via ERK1/2 signaling pathway.
Pang X; Wang SS; Zhang M; Jiang J; Fan HY; Wu JS; Wang HF; Liang XH; Tang YL
Cancer Immunol Immunother; 2021 Apr; 70(4):1015-1029. PubMed ID: 33104837
[TBL] [Abstract][Full Text] [Related]
6. Vorinostat decrease M2 macrophage polarization through ARID1A
Hsieh TH; Hsu CY; Wu CW; Wang SH; Yeh CH; Cheng KH; Tsai EM
Biomed Pharmacother; 2023 May; 161():114500. PubMed ID: 36958195
[TBL] [Abstract][Full Text] [Related]
7. [Oral Squamous Cell Carcinoma-Derived Cell-Free DNA Modulates Stemness and Migration of Oral Squamous Cell Carcinoma Cell Line by Inducing M2 Macrophage Polarization].
Zheng SZ; Meng L; Ren FL; Ren CX; Li X; Wang DD; Sun HC
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):510-516. PubMed ID: 37248576
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of HMGB1 inhibits the crosstalk between oral squamous cell carcinoma cells and tumor-associated macrophages.
Wen J; Yin P; Su Y; Gao F; Wu Y; Zhang W; Chi P; Chen J; Zhang X
Int Immunopharmacol; 2023 Jun; 119():110259. PubMed ID: 37141670
[TBL] [Abstract][Full Text] [Related]
9. Upregulated histone deacetylase 2 gene correlates with the progression of oral squamous cell carcinoma.
Krishna A; Singh V; Singh S; Kumar S; Kumar V; Mehrotra D; Singh US; Mahdi AA
Cancer Biomark; 2020; 29(4):543-552. PubMed ID: 32865179
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma.
Sakuma T; Uzawa K; Onda T; Shiiba M; Yokoe H; Shibahara T; Tanzawa H
Int J Oncol; 2006 Jul; 29(1):117-24. PubMed ID: 16773191
[TBL] [Abstract][Full Text] [Related]
11. HDAC6-dependent deacetylation of TAK1 enhances sIL-6R release to promote macrophage M2 polarization in colon cancer.
Xu G; Niu L; Wang Y; Yang G; Zhu X; Yao Y; Zhao G; Wang S; Li H
Cell Death Dis; 2022 Oct; 13(10):888. PubMed ID: 36270986
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of macrophage polarization in early stage oral squamous cell carcinomas.
Weber M; Iliopoulos C; Moebius P; Büttner-Herold M; Amann K; Ries J; Preidl R; Neukam FW; Wehrhan F
Oral Oncol; 2016 Jan; 52():75-84. PubMed ID: 26728105
[TBL] [Abstract][Full Text] [Related]
13. Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions.
Carenzo A; Serafini MS; Roca E; Paderno A; Mattavelli D; Romani C; Saintigny P; Koljenović S; Licitra L; De Cecco L; Bossi P
Cells; 2020 Aug; 9(8):. PubMed ID: 32756466
[TBL] [Abstract][Full Text] [Related]
14. Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p.
Cai J; Qiao B; Gao N; Lin N; He W
Am J Physiol Cell Physiol; 2019 May; 316(5):C731-C740. PubMed ID: 30811223
[TBL] [Abstract][Full Text] [Related]
15. IGF2BP2 maybe a novel prognostic biomarker in oral squamous cell carcinoma.
Wang X; Xu H; Zhou Z; Guo S; Chen R
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35129592
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of HDAC6 induces pro-inflammatory responses by regulating ROS-MAPK-NF-κB/AP-1 signaling pathways in macrophages.
Youn GS; Lee KW; Choi SY; Park J
Free Radic Biol Med; 2016 Aug; 97():14-23. PubMed ID: 27208785
[TBL] [Abstract][Full Text] [Related]
17. miR-433 inhibits oral squamous cell carcinoma (OSCC) cell growth and metastasis by targeting HDAC6.
Wang XC; Ma Y; Meng PS; Han JL; Yu HY; Bi LJ
Oral Oncol; 2015 Jul; 51(7):674-82. PubMed ID: 25962939
[TBL] [Abstract][Full Text] [Related]
18. The Expression of SIRT6 Is Associated With Treatment Outcome in Elder Patients With Oral Cancer.
Yoshii H; Sekihara K; Ideta Y; Nakajima S; Kato I; Okubo-Sato M; Sugiura K; Mitsudo K; Kioi M
Anticancer Res; 2022 Aug; 42(8):3815-3823. PubMed ID: 35896220
[TBL] [Abstract][Full Text] [Related]
19. High expression of Rab31 confers a poor prognosis and enhances cell proliferation and invasion in oral squamous cell carcinoma.
Li X; Zhu F; Liu Z; Tang X; Han Y; Jiang J; Ma C; He Y
Oncol Rep; 2021 Mar; 45(3):1182-1192. PubMed ID: 33469675
[TBL] [Abstract][Full Text] [Related]
20. Identification of RNA-splicing factor Lsm12 as a novel tumor-associated gene and a potent biomarker in Oral Squamous Cell Carcinoma (OSCC).
Dong Y; Xue L; Zhang Y; Liu C; Zhang Y; Jiang N; Ma X; Chen F; Li L; Yu L; Liu X; Shao S; Guan S; Zhang J; Xiao Q; Li H; Dong A; Huang L; Shi C; Wang Y; Fu M; Lv N; Zhan Q
J Exp Clin Cancer Res; 2022 Apr; 41(1):150. PubMed ID: 35449073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
